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Introduction
Neurodegeneration progresses from reversible down-regulation of synaptic function to irreversible synapse loss and neuronal death, so rescue at such an early stage of synaptic loss offers an attractive approach for therapeutic intervention (Mallucci, 2009; Wishart et al., 2006) . Elucidating mechanisms causing neurodegenerative process requires capturing an earlier synaptic perturbation, which is not always easy in existing in vivo and in vitro models of neurodegeneration (Boekhoorn et al., 2006; Soto and Estrada, 2008 ). Here we focus on early stages of synaptic dysfunction prior to neurite fragmentation in primary neurons with reduced level of heme and on identifying factors triggering synaptic loss that has greater potential to facilitate pharmacological strategies to reverse neurodegeneration.
Deficiency of heme is detrimental to neurons and is a contributory factor in cell ageing (Chernova et al., 2006 ), Alzheimer's disease (Atamna and Frey, 2004) and drug-induced neurotoxicity (Meyer et al., 2005) . It also diminishes neuron-specific gene expression, alters cellular signalling and induces apoptosis (Zhu Y, 2002) . Heme synthesis is up-regulated during differentiation of cultured neuronal cells (Shinjyo and Kita, 2006) and exogenous heme promotes outgrowth of neurites (Ishii and Maniatis, 1978) . Heme exists in at least two pools in cells: heme bound within hemoproteins and "free" heme, i.e.
not associated with a protein. A portion of the unbound heme forms a regulatory pool that mediates a signalling role through binding to heme-regulatory motifs in proteins and modulating their functions; this includes ion channels (Tang et al., 2003) , transcription factors (Ogawa et al., 2001 ) and nuclear M O L # 6 9 8 3 1
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Here we tested the hypothesis that heme is necessary for the regulation of NMDAR and that a lack of "free" heme rapidly causes this ion channel dysfunction. We have examined the early stage of heme deficiency in cortical cultures and identified an early NMDAR impairment. Failure of NMDAR function occurred shortly (16-24 h) after reduction of regulatory heme and was reflected by markedly decreased NMDAR currents and Ca 2+ influx. This correlated with a reduction in the phosphorylation of the NR2B subunit of NMDARs. Additionally, NMDARdependent cGMP production was compromised and dendritic spine formation reduced. Exogenous heme rescued the ion channel function and spine formation, but only if normal levels of NR2B phosphorylation were resumed. We have demonstrated that heme modulates NMDAR function and tyrosine phosphorylation of NR2B subunit within minutes in a signalling mode and requires SFKs activity. Heme bound to major hemoproteins was preserved and the functions of tested proteins were unaffected. These findings suggest that early synaptic impairment following inhibition of heme synthesis is caused by reduction of regulatory heme. We conclude that NMDAR failure occurs prior to neurite fragmentation at the early stage of heme deficiency and may be a causal factor in neurodegeneration.
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0.4 μCi of [3, H]aminolevulinic acid hydrochloride (ALA; 2.6 Ci/mmol; PerkinElmer, Boston, MA)
for 24 h. Heme was extracted from the cells by acetone-HCl and diethyl ether. The amount of radioactivity in extracted heme was measured by scintillation counting as described previously (Chernova et al., 2007) . Total recovery of radioactivity from all fractions was the same for treated and untreated cells.
RNA extraction and quantitative real-time PCR analysis. Total RNA was isolated from treated and untreated cells at different time points by using TRI-reagent (Sigma, Dorset, UK) and cDNA synthesis was performed using random primers and Superscript II (Invitrogen). PCR primers were selected using the Primer Express version 2.0 Software program (Applied Biosystems, Foster City, CA). Primers sequences were as follows: β-actin forward primer, 5'-GATTACTGCTCTGGCTCCTAGCA-3', reverse primer, 5'-GTGGACAGTGAGGCCAGGAT-3'; δ-aminolevulinate synthase 1 (ALAS1) forward primer,
5'-TCTTC-CGCAAGGCCAGTCT-3', reverse primer, 5'-TGGGCTTGAGCAGCCTCTT-3'; CYP4x1
forward primer 5'-CCTGGACATAATAATGAAATGTGCTT-3'; reverse primer, 5'-
CTTCACGTAAGACTCATAGGTGCC-3';
Primers were designed to cross exon-exon boundaries. PCR was performed using SYBR Green PCR Master Mix, primers, and 10 ng of reverse-transcribed cDNA in the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA) as described previously (Kannan et al., 2010) .
Quantification was performed using the comparative CT method (ΔΔCT). Data are presented as the mean ± SD (n = 3-8 for each group). Statistical significance was assessed as p < 0.05 using one-way ANOVA.
Immunocytochemistry. After treatment, cells were fixed with 4% paraformaldehyde at room temperature for 20 min and permeabilized with 0.2% Triton X-100 (Sigma, Dorset, UK) in PBS for 5 min. Cells were then incubated with rabbit anti-phospo-NR2B (Tyr 1252 or Tyr 1336) (R&D Systems, Abingdon, UK) and mouse anti-PSD-95 antibody (NeuroMab, Davis, CA, USA) at room temperature for 1 h. Secondary antibodies (goat anti-rabbit Alexa Fluor 546 and goat anti-mouse Alexa Fluor 488 at M O L # 6 9 8 3 1 8 1:500) were then added for 1h, followed by nuclear staining with 300 nM 4'-6-diamidino-2-phenylindole (DAPI) for 10 min. Secondary antibodies alone were used as specificity controls and uniformly resulted in very low background levels of fluorescence.
Transfection of cortical neurons. At 7DIV, neurons were transfected with plasmids expressing FLAGtagged tdTomato as a cell fill provided by Dr. Michael J. Schell (Dept. of Pharmacology, Uniformed
Services University, Bethesda) to visualize dendritic morphology. A total of 0.5μg DNA and 1μLLipofectamine2000 (Invitrogen) was premixed according to the manufacturer's instructions, and added to cultures (0.5x 10 6 cells) growing on bottom glass chambers ( Fisher Scientific, Loughborough, UK) in 900μL of medium. After 6 h the medium was replaced with a fresh 900μL of serum-free Neurobasal medium supplemented as described above. Transfection efficiency was estimated to be less than 2%. Neurons were imaged at 13DIV.
Imaging and quantification of spines. Cortical neurons with pyramidal morphology were selected for analysis from the transfected cell population. Images of cultured cells were obtained with a Zeiss LSM 510 META confocal microscope equipped with a 63x oil immersion lens. Images were collected as a series of Z sections (approx. 0.5 micron). Images were reconstructed using Volocity software (Improvision, Coventry, UK). Total protrusions from the dendrite (spines) were quantified over unit length and expressed as number per 10 μm of the neurites. Only fields with a low density of transfected neurons were used to quantify the spines length and number.
Immunoblotting. Proteins were extracted from primary neurons using NP-40 lysis buffer (1%NP-40, 20mM Tris-HCl pH8.0, 137mMNaCl, 10%glycerol, 2mM EDTA, 1mM sodium orthovanadate, 10 μg/μL leupeptin, 10 μg/μL aprotinin) and brief sonication. Microsomal fraction was prepared as described previously (Kapoor et al., 2006 . Blots were subsequently exposed to a second primary antibody against α-tubulin, to verify equivalent protein loading and transfer. Bands were detected by enhanced chemiluminescence (GE Healthcare, Buckinghamshire, UK), exposed to X-ray films under nonsaturating conditions. Results were quantified using densitometry and Image Quant 5.2 software.
All comparisons were made within blots. Statistical significance was estimated using two-tailed Student's t test.
NMDA application. Agonist application experiments on primary cortical cultures were performed using a Picospritzer III (Intracel, Frederick, MD) connected to a patch electrode filled with artificial cerebrospinal fluid (aCSF) containing 100 μM NMDA (Sigma, Dorset, UK). The tip of the electrode was placed near a patch-clamped cortical neuron, and the maximal response to the agonist was optimized by adjusting the pipette position. Puffs were applied for 30 ms every 8 s (20 psi) in the presence of (6,7-dinitroquinoxaline-2,3-dione) (DNQX, 10 μM), D-serine (10 μM), and bicuculline (10 μM high ΔΨm, the dye crosses the membrane and forms aggregates, which appear red under UV light.
Living neurons were stained and observe immediately with a microscope using a long-pass filter (fluorescein and rhodamine). In healthy cells, the mitochondria were stained red following aggregation of the DePsipher within the mitochondria. In cells with disrupted ΔΨm, the dye remains in its monomeric form in the cytoplasm and appears entirely green.
Measurement of ATP in neurons.
Cultured neurons were treated with 250μM SA for 1-6 days and harvested at 12DIV. 
Results
Inhibition of heme synthesis promptly reduced regulatory pool of intracellular heme.
To examine the chronology of the neuronal deficit with reduced heme we inhibited its synthesis for 1-6 days by treatment with 250μM succinylacetone (SA), a specific inhibitor of aminolevulinic acid dehydratase (ALAD) (Sassa and Nagai, 1996) . Heme synthesis was reduced by about 50% ( Figure 1A ), causing 17% ±6% decrease of total intracellular heme ( Figure 1B ). This reduction was accompanied by a marked increase in the expression of ALAS1 ( Figure 1C ), the gene encoding aminolevulinic acid synthase, which is under negative transcriptional feedback control by the regulatory pool of intracellular heme (Sassa, 2004; Sassa and Nagai, 1996) . The up-regulation of ALAS1 expression in SA-treated neurons indicated that the decrease in heme was physiologically significant, and this was a rapid process, occurring within hours after inhibition of synthesis. After 16 h of SA treatment ALAS1 mRNA increased two-fold, similar to the up-regulation observed in chronically-deficient neurons (Chernova et al., 2006 ). An increased amount of ALAS1 protein in response to reduced heme levels was detected in these SA-treated cultures ( Figure 1D ), consistent with previously shown regulation by "free" heme via alterations in protein half-lives (Zheng et al., 2008) . By contrast, when heme was added back to SAtreated cells there was a 24 ± 2% increase in intracellular heme, accompanied by a decrease in ALAS1 expression, again consistent with a regulated physiological response (Figure 1 B, C). Our results suggest that the regulatory pool of heme was compromised within hours if de novo synthesis was inadequate.
We examined how a lack of regulatory heme affected neuronal function, and tested if NMDAR was compromised in neurons with reduced regulatory heme. We chose a 24h time-point of heme synthesis inhibition as this corresponded to the depleted regulatory heme pool, reflected by a two-fold upregulation of ALAS1, and a relatively small (17%) reduction of total cellular heme. was affected. SA-treated neurons showed diminished Ca 2+ influx ( Figure 4A ) in response to NMDA (Δ ratio calculated as peak ratio minus basal ratio). Peak Ca 2+ responses were reduced at all time-points of SA treatment ( Figure 4B ). Heme readmission during 24h of SA treatment recovered the peak Ca 2+ responses to control levels ( Figure 4B ). The data confirm that NMDAR function is affected within 24 h after inhibition of heme biosynthesis.
NMDAR-dependent production of cGMP is affected by reduction of intracellular heme.
Neuronal nitric oxide synthase (nNOS) is activated by Ca 2+ influx through NMDAR, leading to downstream production of cGMP following NO activation of soluble guanylate cyclase.
Production of cGMP in response to NMDAR stimulation in cultures with low heme was significantly reduced by 22±2 % compared to control cultures ( Figure 4C ). The response to NMDA was affected after 16 h of inhibition of heme synthesis, and as NMDAR function declined with longer SA treatment, so did cGMP production (by 38 ± 4% at 42 h after SA addition). These results provide further evidence of NMDAR functional impairment as an early change in the neurons with compromised availability of heme.
Heme deficiency reduces dendritic spine number. Heme modulates NMDAR function and NR2B phosphorylation within minutes.
To examine if the potentiation of NMDA-mediated current by heme is a signalling event, we conducted whole-cell patch clamp recordings simultaneously with re-introducing heme to the heme-deficient neurons and recorded for 13 minutes after which currents reached plateau levels under all recording conditions ( Figure 6A ). The neurons treated with SA for 24h showed a 60% reduction in NMDAevoked currents ( Figure 6A , blue diamonds) over a recording time of 13 minutes which is consistent with a dialysis process and a current run down. Heme was introduced into the bath solution after two minutes of recording and caused a 40% rise of the NMDAR current (red square; after an initial 2-minute decline prior to heme addition). When heme was present in the patching pipette, there was no initial decline and the increase of the current started immediately ( Figure 6A , green triangles). At the13 min time-point NMDA-evoked currents were ~140% of initial currents values if heme was added to the bath, and ~110% if heme was present in the pipette. In contrast, in SA-treated cells currents were only ~40% of initial values after 13 minutes of recording. Comparison of the three curves showed that by 10 minutes exposure to heme the NMDAR current is 2-3 fold larger than in the absence of heme.
These alterations of the ion channel function correlated with the changes in NR2B phosphorylation levels upon re-admission of heme to heme-deficient neurons ( Figure 6B , C). At a 15 min time-point NR2B phosphorylation of NR2B at Tyr1252 and Tyr1336 were recovered to control levels. However, if these neurons were pre-treated for 2h with PP2 the rescue effect of heme was abolished, similar to the
changes observed in cultures co-treated with heme and SA for 24h. These data show that regulation of NMDAR by heme is exerted rapidly and suggest a phosphorylation-dependent signalling mechanism.
Heme is preserved in major hemoproteins in neurons despite depletion of regulatory pool.
Depletion of heme from the regulatory pool clearly occurred within hours of SA treatment. We investigated what effect this treatment had on various hemoprotein functions in neurons?
Many mitochondrial proteins are hemoproteins, including those engaged in the electron transport chain and ATP generation. Mitochondrial membrane potential (ΔΨm) and ATP generation were monitored after inhibition of heme synthesis to determine whether mitochondrial hemoproteins functions were affected in neurons when total cellular heme was reduced by ~17%. Inhibition of heme synthesis for at least 72 h had no effect on ΔΨm ( Figure 7A , B), consistent with a well sustained ATP generation in SAtreated neurons. Further measurement of ATP concentration (up to 6 days of heme synthesis inhibition) revealed that mitochondrial function was also unaffected in these cultures ( Figure 7C ). These data show that heme was not depleted from mitochondrial hemoproteins under these conditions. Soluble guanylate cyclase (sGC) is a hemoprotein, which on binding NO to heme increases cGMP production up to 300-fold (Ballou et al., 2002) . sGC activation by the NO donor S-nitroso-Nacetylpenicillamine ( SNAP) was measured as the ratio of basal to stimulated cGMP accumulation and was similar in control cultures and those treated with SA for 42 h ( Figure 8A ) demonstrating that the capacity of sGC to generate cGMP was unaffected.
The hemoprotein neuronal nitric oxide synthase (nNOS) catalyzes the NADPH-dependent oxidation of L-arginine to citrulline and NO (White and Marletta, 1992) . nNOS is a homodimer with heme as a prosthetic group controlling subunit dimerization and the quaternary structure of nNOS (Klatt et al., 1996) . In contrast heme-deficient enzyme (apo-nNOS) is an inactive monomer which degrades rapidly M O L # 6 9 8 3 1 1 9
Discussion
We previously showed that heme deficiency in primary neurons causes neuronal degeneration (Chernova et al., 2007) , however the mechanisms triggering neuronal damage are not well understood.
Here we explored the mechanisms by which a deficit of heme affects synaptic function at an early stage of neurodegeneration, prior to neurite fragmentation in primary neurons. We have shown early loss of NMDAR function which correlated with reduced phosphorylation of NR2B subunits. Reduced NMDAR currents and Ca 2+ influx affected NMDAR-dependent cGMP production and were accompanied by deficient formation of dendritic spines. In this study we used selective and specific inhibition of the second enzyme ALAD in the heme synthetic pathway which remains the optimal means of modulating intracellular heme in vivo and in vitro (Zhu Y, 2002) . ALAS1 is the first and rate limiting enzyme, and consistent with depletion of the regulatory heme pool we monitored increased expression of this gene (Sassa and Nagai, 1996) and protein (Zheng et al., 2008) , which is the generally accepted approach to reflect "free" heme levels (Raghuram et al., 2007) . In our model the rate of heme synthesis was reduced by ~50% while total intracellular heme was reduced by ~17%, suggesting strong homeostatic mechanisms and supporting previous studies of heme turnover and transport (Maines and Gibbs, 2005) . However, the reduction of heme cannot be attributed to reduction of the regulatory pool alone, which has been estimated as <100nM (Sassa and Nagai, 1996) . This decrease could be explained by depletion of the regulatory pool and heme from cellular storage. Such heme storage was demonstrated in astrocytes and involved a reputed heme transporter HCP1 (Dang et al., 2010) . It is plausible that core functions utilising co-factor heme (e.g. respiratory chain in mitochondrial cytochromes) would be protected by homeostatic mechanisms.
The dynamics of heme depletion in neurons were reflected by apparent reduction of regulatory heme within hours, whereas heme bound in hemoproteins remained at sufficient levels. Mitochondrial , 1987) . Our data did not contradict these suggestions but indicated that more time is required to develop heme deficiency in these functional compartments.
In contrast to hemoproteins, the regulatory pool of heme was depleted promptly after starting treatment and resulted in NMDAR dysfunction. After 24 h of SA treatment NMDA-evoked current was decreased by more than 50%, similar to reduction monitored in the chronic model after 12 days of inhibition. This reduction cannot be related to a direct effect of SA on the receptor because in the presence of heme SAtreated neurons showed a large response to NMDA, similar to control. Together these findings lead to the conclusion that depletion of regulatory heme rapidly compromises NR2B phosphorylation and causes dysfunction of NMDARs; this compromises calcium-dependent signalling pathways, triggers changes in cGMP production and dendritic spine formation. Synaptic changes precede depletion of heme from major hemoproteins. Further exploration of heme interaction with NMDAR complex and understanding how exactly the effects of heme are exerted and could be modulated by drugs, may provide new insights into reversal of neurodegeneration. 
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